Our People


Hanqing Li

Investment Analyst

Hanqing is an Investment Analyst for MSD GHI Fund and is responsible for supporting all areas of digital health.  Prior to joining MSD, Hanqing was a technical specialist at Finnegan, Henderson, Farabow, Garrett & Dunner, where her responsibilities included conducting due diligence and freedom to operate analyses in the life sciences industry; drafting patent applications; patent portfolio management; and patent prosecution in jurisdictions around the world.  Hanqing also worked in R&D for Quantgene, a start-up focused on the detection of early-stage cancers using liquid biopsies.  Hanqing holds a Ph.D. in Biology from the California Institute of Technology, where  her research focused on the development of assays for detecting protein-protein interactions, as well as their utilization in the study of the neuromuscular junction in D. melanogaster models.